New York State Common Retirement Fund Dice Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$25.86 - $46.71 $47,272 - $85,385	-1,828 Reduced 9.66%	17,087 $794,000
Q1 2023 May 02, 2023	SELL	$26.05 - $32.31 $97,244 - $120,613	-3,733 Reduced 16.48%	18,915 $542,000
Q4 2022 Jan 30, 2023	SELL	$19.77 - $42.23 $55,019 - $117,526	-2,783 Reduced 10.94%	22,648 $707,000
Q3 2022 Nov 08, 2022	BUY	$14.97 - $22.65 $81,332 - $123,057	5,433 Added 27.17%	25,431 $516,000
Q2 2022 Aug 04, 2022	BUY	$13.19 - $22.1 $89,467 - $149,904	6,783 Added 51.33%	19,998 $310,000
Q1 2022 May 05, 2022	BUY	$14.54 - $25.02 $155,796 - $268,089	10,715 Added 428.6%	13,215 $253,000
Q4 2021 Feb 02, 2022	BUY	$22.41 - $37.54 $56,025 - $93,850	2,500 New	2,500 $63,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.